{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:14:42Z","timestamp":1788146082894,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"DOI":"10.1007\/s11934-026-01360-1","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:51:32Z","timestamp":1788144692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Comprehensive Review of Minimally Invasive Surgical Therapies for Voiding Dysfunction in Benign Prostatic Hyperplasia: Past Failures, Contemporary Successes and Future Innovations"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1806-0830","authenticated-orcid":false,"given":"Shreya","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Welliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"5","key":"1360_CR1","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.juro.2007.01.005","volume":"177","author":"JN Armitage","year":"2007","unstructured":"Armitage JN, Cathcart PJ, Rashidian A, De Nigris E, Emberton M, van der Meulen JH. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature. J Urol. 2007;177(5):1619\u201324. https:\/\/doi.org\/10.1016\/j.juro.2007.01.005.","journal-title":"J Urol"},{"issue":"3","key":"1360_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0090-4295(94)80093-6","volume":"44","author":"JE Oesterling","year":"1994","unstructured":"Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. Urology. 1994;44(3):353\u201362. https:\/\/doi.org\/10.1016\/S0090-4295(94)80093-6.","journal-title":"Urology"},{"issue":"2","key":"1360_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41391-024-00915-y","volume":"28","author":"C Cerrato","year":"2025","unstructured":"Cerrato C, Antoniou V, Somani BK. Prostatic stents: a systematic review and analysis of functional outcomes and complication rate. Prostate Cancer Prostatic Dis. 2025;28(2):318\u201327. https:\/\/doi.org\/10.1038\/s41391-024-00915-y.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"9","key":"1360_CR4","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1464-410X.2004.05155.x","volume":"94","author":"S Masood","year":"2004","unstructured":"Masood S, Djaladat H, Kouriefs C, Keen M, Palmer JH. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int. 2004;94(9):1271\u20134. https:\/\/doi.org\/10.1111\/j.1464-410X.2004.05155.x.","journal-title":"BJU Int"},{"issue":"2","key":"1360_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1148\/radiology.177.2.1699247","volume":"177","author":"NF Wasserman","year":"1990","unstructured":"Wasserman NF, Reddy PK, Zhang G, Berg PA. Experimental treatment of benign prostatic hyperplasia with transurethral balloon dilation of the prostate: preliminary study in 73 humans. Radiology. 1990;177(2):485\u201394. https:\/\/doi.org\/10.1148\/radiology.177.2.1699247.","journal-title":"Radiology"},{"issue":"1","key":"1360_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-5347(17)39374-6","volume":"144","author":"SL Goldenberg","year":"1990","unstructured":"Goldenberg SL, Perez-Marrero RA, Lee LM, Emerson L. Endoscopic balloon dilation of the prostate: early experience. J Urol. 1990;144(1):83\u20138. https:\/\/doi.org\/10.1016\/S0022-5347(17)39374-6.","journal-title":"J Urol"},{"issue":"3","key":"1360_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0022-5347(17)37331-7","volume":"147","author":"H Lepor","year":"1992","unstructured":"Lepor H, Sypherd D, Machi G, Derus J. Randomized double-blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. J Urol. 1992;147(3):639\u201344. https:\/\/doi.org\/10.1016\/S0022-5347(17)37331-7.","journal-title":"J Urol"},{"issue":"6","key":"1360_CR8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.juro.2015.06.091","volume":"194","author":"C Welliver","year":"2015","unstructured":"Welliver C, Kottwitz M, Feustel P, McVary K. Clinically and statistically significant changes seen in sham surgery arms of randomized, controlled benign prostatic hyperplasia surgery trials. J Urol. 2015;194(6):1682\u20137.","journal-title":"J Urol"},{"issue":"3","key":"1360_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.eururo.2012.10.005","volume":"63","author":"M Marberger","year":"2013","unstructured":"Marberger M, Chartier-Kastler E, Egerdie B, et al. A randomized double-blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia. Eur Urol. 2013;63(3):496\u2013503. https:\/\/doi.org\/10.1016\/j.eururo.2012.10.005.","journal-title":"Eur Urol"},{"issue":"5","key":"1360_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1159\/000049826","volume":"40","author":"G Savoca","year":"2001","unstructured":"Savoca G, De Stefani S, Gattuccio I, Paolinelli D, Stacul F, Belgrano E. Percutaneous ethanol injection of the prostate as minimally invasive treatment for benign prostatic hyperplasia: preliminary report. Eur Urol. 2001;40(5):504\u20138. https:\/\/doi.org\/10.1159\/000049826.","journal-title":"Eur Urol"},{"issue":"4","key":"1360_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.eururo.2004.06.001","volume":"46","author":"P Grise","year":"2004","unstructured":"Grise P, Plante M, Palmer J, et al. Evaluation of transurethral ethanol ablation of the prostate for symptomatic benign prostatic hyperplasia: a European multicenter evaluation. Eur Urol. 2004;46(4):496\u2013502. https:\/\/doi.org\/10.1016\/j.eururo.2004.06.001.","journal-title":"Eur Urol"},{"issue":"1","key":"1360_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0302-2838(03)00218-5","volume":"44","author":"AR Zlotta","year":"2003","unstructured":"Zlotta AR, Giannakopoulos X, Maehlum O, Ostrem T, Schulman CC. Long-term evaluation of transurethral needle ablation of the prostate for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol. 2003;44(1):89\u201393. https:\/\/doi.org\/10.1016\/S0302-2838(03)00218-5.","journal-title":"Eur Urol"},{"issue":"3","key":"1360_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.juro.2006.10.042","volume":"177","author":"DJ Rosario","year":"2007","unstructured":"Rosario DJ, Woo HH, Chapple CR. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails. J Urol. 2007;177(3):1047\u201351. https:\/\/doi.org\/10.1016\/j.juro.2006.10.042.","journal-title":"J Urol"},{"issue":"2","key":"1360_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000019833","volume":"35","author":"JH Lynch","year":"1999","unstructured":"Lynch JH, H\u00f6fner K. Transurethral microwave thermotherapy. Eur Urol. 1999;35(2):129\u201337. https:\/\/doi.org\/10.1159\/000019833.","journal-title":"Eur Urol"},{"key":"1360_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004135.pub3","volume":"9","author":"RM Hoffman","year":"2012","unstructured":"Hoffman RM, Monga M, Elliott SP, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012;9:CD004135. https:\/\/doi.org\/10.1002\/14651858.CD004135.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1360_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00345-025-05884-y","volume":"43","author":"B Akgul","year":"2025","unstructured":"Akgul B, Tozsin A, Ayd\u0131n A, et al. Reintervention rates after minimally invasive benign prostatic hyperplasia therapies: a systematic review including industry involvement. World J Urol. 2025;43(1):494. https:\/\/doi.org\/10.1007\/s00345-025-05884-y.","journal-title":"World J Urol"},{"issue":"3","key":"1360_CR17","first-page":"8802","volume":"24","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG, Barkin J, Gange SN, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24(3):8802\u201313.","journal-title":"Can J Urol"},{"issue":"4","key":"1360_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.eururo.2015.04.024","volume":"68","author":"J S\u00f8nksen","year":"2015","unstructured":"S\u00f8nksen J, Barber NJ, Speakman MJ, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68(4):643\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2015.04.024.","journal-title":"Eur Urol"},{"issue":"Suppl 3","key":"1360_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bju.13666","volume":"118","author":"D Rukstalis","year":"2016","unstructured":"Rukstalis D, Rashid P, Bogache WK, et al. 24-month durability after crossover to the prostatic urethral lift from randomized, blinded sham. BJU Int. 2016;118(Suppl 3):14\u201322. https:\/\/doi.org\/10.1111\/bju.13666.","journal-title":"BJU Int"},{"issue":"3","key":"1360_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","volume":"22","author":"D Rukstalis","year":"2019","unstructured":"Rukstalis D, Grier D, Stroup SP, et al. Prostatic urethral lift for obstructive median lobes: 12-month results of the MedLift study. Prostate Cancer Prostatic Dis. 2019;22(3):411\u20139. https:\/\/doi.org\/10.1038\/s41391-018-0118-x.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Suppl 2","key":"1360_CR21","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.21037\/tau.2017.04.10","volume":"6","author":"P Chin","year":"2017","unstructured":"Chin P, Robertson P. Medium-term efficacy of the prostatic urethral lift. Transl Androl Urol. 2017;6(Suppl 2):S122\u201332. https:\/\/doi.org\/10.21037\/tau.2017.04.10.","journal-title":"Transl Androl Urol"},{"issue":"5","key":"1360_CR22","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195(5):1529\u201338. https:\/\/doi.org\/10.1016\/j.juro.2015.10.181.","journal-title":"J Urol"},{"issue":"3","key":"1360_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021;206(3):715\u201324. https:\/\/doi.org\/10.1097\/JU.0000000000001778.","journal-title":"J Urol"},{"issue":"1","key":"1360_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279883","volume":"18","author":"T Winkler","year":"2023","unstructured":"Winkler T, von Klot CAJ, Madersbacher S, Kuczyk MA, Wolters M. Rez\u016bm water vapor thermal therapy for treatment of lower urinary tract symptoms: a retrospective single-centre analysis from a German high-volume centre. PLoS One. 2023;18(1):e0279883. https:\/\/doi.org\/10.1371\/journal.pone.0279883.","journal-title":"PLoS One"},{"issue":"1","key":"1360_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00345-025-05793-0","volume":"43","author":"M Samir","year":"2025","unstructured":"Samir M, Mahmoud MA, Abdelmonem HA, Elrefaie M, Gad KA. A comparative analysis of the outcomes of Rez\u016bm therapy based on prostate size: a four-year retrospective analysis. World J Urol. 2025;43(1):443. https:\/\/doi.org\/10.1007\/s00345-025-05793-0.","journal-title":"World J Urol"},{"issue":"3","key":"1360_CR26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80914","volume":"17","author":"CY Lim","year":"2025","unstructured":"Lim CY, Lai CC, Tsai YW. Comparison of durability between Rez\u016bm water vapor therapy and UroLift in treating benign prostatic hyperplasia: a multicenter propensity score-matched analysis. Cureus. 2025;17(3):e80914. https:\/\/doi.org\/10.7759\/cureus.80914.","journal-title":"Cureus"},{"issue":"3","key":"1360_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/JU.0000000000003568","volume":"210","author":"SA Kaplan","year":"2023","unstructured":"Kaplan SA, Moss JL, Freedman SJ, et al. The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2023;210(3):500\u20139. https:\/\/doi.org\/10.1097\/JU.0000000000003568.","journal-title":"J Urol"},{"issue":"3","key":"1360_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41391-024-00833-z","volume":"27","author":"SA Kaplan","year":"2024","unstructured":"Kaplan SA, Moss JL, Freedman SJ, et al. Two-year long-term follow-up of treatment with the Optilume BPH Catheter System in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study). Prostate Cancer Prostatic Dis. 2024;27(3):531\u20136. https:\/\/doi.org\/10.1038\/s41391-024-00833-z.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"8","key":"1360_CR29","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s00345-023-04473-1","volume":"41","author":"M Pichardo","year":"2023","unstructured":"Pichardo M, Rijo E, Espino G, et al. Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study. World J Urol. 2023;41(8):2209\u201315. https:\/\/doi.org\/10.1007\/s00345-023-04473-1.","journal-title":"World J Urol"},{"issue":"4","key":"1360_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41391-021-00362-z","volume":"24","author":"SA Kaplan","year":"2021","unstructured":"Kaplan SA, Pichardo M, Rijo E, Espino G, Lay RR, Estrella R. One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2021;24(4):1073\u20139. https:\/\/doi.org\/10.1038\/s41391-021-00362-z.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1360_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","volume":"153","author":"B Chughtai","year":"2021","unstructured":"Chughtai B, Elterman D, Shore N, et al. The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial. Urology. 2021;153:270\u20136. https:\/\/doi.org\/10.1016\/j.urology.2020.12.022.","journal-title":"Urology"},{"key":"1360_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000004896","author":"SA Kaplan","year":"2026","unstructured":"Kaplan SA, Parekattil SJ, Wu NZ, et al. 12-month outcomes from a randomized, sham-controlled trial evaluating a novel prostatic urethral stent for the treatment of benign prostatic hyperplasia. J Urol. 2026. https:\/\/doi.org\/10.1097\/JU.0000000000004896.","journal-title":"J Urol"},{"issue":"1","key":"1360_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-bioeng-073123-022334","volume":"26","author":"Z Xu","year":"2024","unstructured":"Xu Z, Khokhlova TD, Cho CS, Khokhlova VA. Histotripsy: a method for mechanical tissue ablation with ultrasound. Annu Rev Biomed Eng. 2024;26(1):141\u201367. https:\/\/doi.org\/10.1146\/annurev-bioeng-073123-022334.","journal-title":"Annu Rev Biomed Eng"},{"issue":"4","key":"1360_CR34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.urology.2009.03.049","volume":"74","author":"TL Hall","year":"2009","unstructured":"Hall TL, Hempel CR, Wojno K, Xu Z, Cain CA, Roberts WW. Histotripsy of the prostate: dose effects in a chronic canine model. Urology. 2009;74(4):932\u20137. https:\/\/doi.org\/10.1016\/j.urology.2009.03.049.","journal-title":"Urology"},{"issue":"1","key":"1360_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ultrasmedbio.2022.07.014","volume":"49","author":"VA Khokhlova","year":"2023","unstructured":"Khokhlova VA, Rosnitskiy PB, Tsysar SA, et al. Initial assessment of boiling histotripsy for mechanical ablation of ex vivo human prostate tissue. Ultrasound Med Biol. 2023;49(1):62\u201371. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2022.07.014.","journal-title":"Ultrasound Med Biol"},{"key":"1360_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.urology.2017.12.033","volume":"114","author":"TG Schuster","year":"2018","unstructured":"Schuster TG, Wei JT, Hendlin K, Jahnke R, Roberts WW. Histotripsy treatment of benign prostatic enlargement using the Vortx Rx system: initial human safety and efficacy outcomes. Urology. 2018;114:184\u20137. https:\/\/doi.org\/10.1016\/j.urology.2017.12.033.","journal-title":"Urology"},{"issue":"1","key":"1360_CR37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/02656736.2021.1905189","volume":"38","author":"Z Xu","year":"2021","unstructured":"Xu Z, Hall TL, Vlaisavljevich E, Lee FT Jr. Histotripsy: the first noninvasive, non-ionizing, non-thermal ablation technique based on ultrasound. Int J Hyperthermia. 2021;38(1):561\u201375. https:\/\/doi.org\/10.1080\/02656736.2021.1905189.","journal-title":"Int J Hyperthermia"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01360-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-026-01360-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01360-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:51:34Z","timestamp":1788144694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-026-01360-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1007\/s11934-026-01360-1","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"45"}}